High-Dose Anthracycline Induction in Adult Acute Lymphocytic Leukemia

This publication has 23 references indexed in Scilit:

• Acute Lymphoblastic Leukemia
  New England Journal of Medicine, 1998
• Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin
  Leukemia, 1998
• Bone marrow transplantation versus chemotherapy for maintenance of second remission of childhood acute lymphoblastic leukemia: A study of the children's cancer group (CCG-1884)
  Medical and Pediatric Oncology, 1997
• Prognostic value of early response to chemotherapy assessed by the day 15 bone marrow aspiration in adult acute lymphoblastic leukemia: A prospective analysis of 437 cases and its application for designing induction chemotherapy trials
  Leukemia Research, 1995
• Induction toxicity in childhood acute lymphoblastic leukemia: A comparison of two schedules of daunorubicin administration
  Medical and Pediatric Oncology, 1995
• Therapy for acute myeloid leukemia and acute lymphoblastic leukemia in adults
  Current Opinion in Oncology, 1991
• Association of delivered drug dose and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features
  Medical and Pediatric Oncology, 1991
• The impact of induction anthracycline on long‐term failure‐free survival in childhood acute lymphoblastic leukemia
  Medical and Pediatric Oncology, 1986
• Combination chemotherapy for acute lymphoblastic leukaemia in adults.
  BMJ, 1978
• Clinical and cytokinetic aspects of remission induction of childhood acute lymphoblastic leukemia (ALL): Addition of an anthracycline to vincristine and prednisone
  Medical and Pediatric Oncology, 1977